Evidence map›Paper›PMID 15326312›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.

Irina L Derkatch, Susan M Uptain, Tiago F Outeiro, Rajaraman Krishnan, Susan L Lindquist, Susan W Liebman

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 126 papers.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 211 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular Crowding: Physiologic Sensing and Control.Annual review of physiology · 2024
    Review
  5. Article
  6. Article
  7. A call to order: Examining structured domains in biomolecular condensates.Journal of magnetic resonance (San Diego, Calif. : 1997) · 2023
    Article
  8. Article
  9. Structural Bases of Prion Variation in Yeast.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Structure and Aggregation Mechanisms in Amyloids.Molecules (Basel, Switzerland) · 2020
    Review
  18. Review
  19. The three faces of Sup35.Yeast (Chichester, England) · 2019
    Review
  20. Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Irina L DerkatchDepartment of Microbiology, New York University School of Medicine, New York, NY 10016, USA.
Susan M Uptain
Tiago F Outeiro
Rajaraman Krishnan
Susan L Lindquist
Susan W Liebman
University of Chicago · USNew York University · USUniversity of Illinois Chicago · USWhitehead Institute for Biomedical Research · US

Funding

YEAST PRION FACTOR (PSI+)R01GM056350 · NIGMS · UNIVERSITY OF NEVADA RENO · PI LIEBMAN, SUSAN W · 1997 to 2018
$6.6M
YEAST PRION DYNAMICS AND CHAPERONE INTERACTIONSR01GM057840 · NIGMS · UNIVERSITY OF CHICAGO · PI ARNSDORF, MORTON F · 2000 to 2003
$1.1M
NIGMS NIH HHS GM56350NIGMS NIH HHS GM57840NIGMS NIH HHS R01 GM056350NIGMS NIH HHS R01 GM057840
6 · The paper itself

Abstract

Prions are infectious protein conformations that are generally ordered protein aggregates. In the absence of prions, newly synthesized molecules of these same proteins usually maintain a conventional soluble conformation. However, prions occasionally arise even without a homologous prion template. The conformational switch that results in the de novo appearance of yeast prions with glutamine/aspargine (Q/N)-rich prion domains (e.g., [PSI+]), is promoted by heterologous prions with a similar domain (e.g., [RNQ+], also known as [PIN+]), or by overexpression of proteins with prion-like Q-, N-, or Q/N-rich domains. This finding led to the hypothesis that aggregates of heterologous proteins provide an imperfect template on which the new prion is seeded. Indeed, we show that newly forming Sup35 and preexisting Rnq1 aggregates always colocalize when [PSI+] appearance is facilitated by the [RNQ+] prion, and that Rnq1 fibers enhance the in vitro formation of fibers by the prion domain of Sup35 (NM). The proteins do not however form mixed, interdigitated aggregates. We also demonstrate that aggregating variants of the polyQ-containing domain of huntingtin promote the de novo conversion of Sup35 into [PSI+]; whereas nonaggregating variants of huntingtin and aggregates of non-polyQ amyloidogenic proteins, transthyretin, alpha-synuclein, and synphilin do not. Furthermore, transthyretin and alpha-synuclein amyloids do not facilitate NM aggregation in vitro, even though in [PSI+] cells NM and transthyretin aggregates also occasionally colocalize. Our data, especially the in vitro reproduction of the highly specific heterologous seeding effect, provide strong support for the hypothesis of cross-seeding in the spontaneous initiation of prion states.

Indexed as

AllelesAmyloidAsparagineGlutaminePeptide Termination FactorsPrionsProtein ConformationSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsTime FactorsAmyloidAsparagineGlutaminePeptide Termination FactorsPrionsRNQ1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSUP35 protein, S cerevisiae

Identifiers

PMID15326312
PMCPMC516497
OpenAlexW1980675329

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.